Milstein Lecture 2022 - mRNA Cancer Vaccines

Add to your list(s) Download to your calendar using vCal

• Ugur Sahin, M.D., Professor Translational Oncology & Immunology, Johannes Gutenberg University Mainz, Co-founder, CEO BioNTech, Germany
• Tuesday 26 July 2022, 10:00-11:00
• In person in the Max Perutz Lecture Theatre (CB2 0QH) and via Zoom, link: https://mrc-lmb-cam-ac-uk.zoom.us/j/94050407947?pwd=ZFZZYkxhd0JsbGJuMFNHQnlzOSsydz09.

If you have a question about this talk, please contact Scientific Meetings Co-ordinator.

The purpose of a therapeutic cancer vaccine is to instruct the patient’s immune system to recognize and eliminate cancer cells. The origins of using mRNA for delivery of cancer vaccines date back to the 1990s. However, early attempts were hampered by low vaccine potency and lack of clinical activity due to various biological and technologies challenges. This talk will provide an overview on the scientific groundwork, key discoveries, inventions, and technological solutions that have paved the development and clinical application of highly potent, personalized mRNA cancer vaccines, a novel approach that for the first time allows a treatment to be individually tailored to the complex genetic profile of a patient’s tumor.

This talk is part of the MRC LMB Seminar Series series.

This talk is included in these lists:

• All Talks (aka the CURE list)
• Biology
• CCC talks for website
• Cambridge Immunology
• Centre for Health Leadership and Enterprise
• In person in the Max Perutz Lecture Theatre (CB2 0QH) and via Zoom, link: https://mrc-lmb-cam-ac-uk.zoom.us/j/94050407947?pwd=ZFZZYkxhd0JsbGJuMFNHQnlzOSsydz09
• Liam
• Life Sciences
• Life Sciences
• ME Seminar
• MRC LMB Seminar Series
• Neurons, Fake News, DNA and your iPhone: The Mathematics of Information
• cri
• my_list
• other talks
• rc781

Note that ex-directory lists are not shown.